Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactobacillus preparation
- Development stage
- Unknown
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral, Intravaginal
01
Overview
**Lactobacillus preparation** is a non-specific label for a probiotic microbial product rather than a uniquely identifiable drug. In the supplied breast-cancer pilot study, the term refers to an **oral 4-strain Lactobacillus combination** containing *Lactobacillus crispatus* LbV 88, *Lactobacillus rhamnosus* LbV 96, *Lactobacillus jensenii* LbV 116, and *Lactobacillus gasseri* LbV 150N, administered as probiotic capsules to improve vaginal microbiota in postmenopausal women receiving chemotherapy. The intended mechanism is microbiome modulation: replenishment of beneficial lactobacilli, restoration of acidic vaginal ecosystem conditions, and suppression of dysbiosis-associated organisms rather than a single defined molecular target. Because the queried name does not uniquely specify one standardized commercial or regulatory product, it is best treated as a **non-specific probiotic combination / microbiome therapy descriptor** rather than a distinct INN drug.
- Other names
- Lactobacillus preparationorally administered Lactobacillus preparationLactobacillus spp. preparation
Beyond the preview
Go deeper on Lactobacillus preparation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lactobacillus preparation.